| Product NDC: | 66336-801 | 
| Proprietary Name: | Levothyroxine sodium | 
| Non Proprietary Name: | Levothyroxine sodium | 
| Active Ingredient(s): | 150 ug/1 & nbsp; Levothyroxine sodium | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 66336-801 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021342 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20110501 | 
| Package NDC: | 66336-801-90 | 
| Package Description: | 90 TABLET in 1 BOTTLE (66336-801-90) | 
| NDC Code | 66336-801-90 | 
| Proprietary Name | Levothyroxine sodium | 
| Package Description | 90 TABLET in 1 BOTTLE (66336-801-90) | 
| Product NDC | 66336-801 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Levothyroxine sodium | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20110501 | 
| Marketing Category Name | NDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | LEVOTHYROXINE SODIUM | 
| Strength Number | 150 | 
| Strength Unit | ug/1 | 
| Pharmaceutical Classes | l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] |